Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (11365)	11/18/1997 10:56:00 AM
From: Andrew H	Respond to of 32384

>>and the indications should coincide with LGND's areas of interest (which would be cancer and psoriasis since both Targretin and Panretin are in trials for those indications).<< Well, if it includes the prosiasis indication, I have no problem. THE CTCL market looks very small to me. Well, if you think my complaining is good for LGND, get ready for a barrage. Got a margin call and have to sell some of our favorite unless it goes up in the next couple of days. Sucks big time. Did hit 14 1/2 earlier, but now back under 14. Where's all our good news?